- 324
- 92 958
BIOS
United States
āđāļāđāļēāļĢāđāļ§āļĄāđāļĄāļ·āđāļ 12 āļĄ.āļ. 2021
BIOS brings together cutting-edge insights from Life Science industry leaders at the forefront of innovation ð
Join us in hearing from Founders, VCs, Profs, & Pharma at the intersection of Tech & Bio ð§Ž
By Alix Ventures: Supporting early stage Life Science startups engineering biology to drive radical advances in human health
_______________________________________________
Alix Ventures, by way of BIOS, is providing this content for general information purposes only. Reference to any specific product or entity does not constitute an endorsement or recommendation by Alix Ventures, BIOS, or its affiliates. The views expressed by guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent. Views and opinions expressed by Alix Ventures employees are those of the employees and do not necessarily reflect the view of Alix Ventures, BIOS, affiliates, and content sponsors.
Join us in hearing from Founders, VCs, Profs, & Pharma at the intersection of Tech & Bio ð§Ž
By Alix Ventures: Supporting early stage Life Science startups engineering biology to drive radical advances in human health
_______________________________________________
Alix Ventures, by way of BIOS, is providing this content for general information purposes only. Reference to any specific product or entity does not constitute an endorsement or recommendation by Alix Ventures, BIOS, or its affiliates. The views expressed by guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent. Views and opinions expressed by Alix Ventures employees are those of the employees and do not necessarily reflect the view of Alix Ventures, BIOS, affiliates, and content sponsors.
Builders #33 w/ Josh Mandel-Brehm - Co-Founder & CEO @ CAMP4 Therapeutics | BIOS
Guest: Josh Mandel-Brehm - Co-Founder & CEO @ CAMP4
Josh Mandel-Brehm is President & Chief Executive Officer of CAMP4 Therapeutics.
Mr. Mandel-Brehm was previously an entrepreneur partner with Polaris Partners and held key business development and operations leadership roles at leading biotech companies. Most recently he served as part of the Business Development group at Biogen, where he led multiple strategic activities and corresponding transactions. Prior to Biogen, Mr. Mandel-Brehm held several roles of increasing responsibility at Genzyme as part of the business development group for the companyâs rare disease business unit.
Mr. Mandel-Brehm earned a BA in Biology from Washington University in St. Louis and holds an MBA from the University of Michigan.
Host: Chris Ghadban
_______________________
Join BIOS Community ð
Become a member, continue the conversation, connect with like-minded Life Science innovators, access exclusive resources, & invite-only eventsâĶ
Apply to Join -docs.google.com/forms/d/e/1FAIpQLSft6P6HhSwMDJbFEW9j7HU6vZwjza9PRNN5ZdSGENj7HwhL7A/viewform
For More Interesting Content ð
ðĶū Website: www.bios.community/
𧎠Podcast: open.spotify.com/show/2HmcPq9k8fYpn60F3hw6Ra?si=uH9wk7SiRAiVUeP1dmwi7Q
𧊠Medium: medium.com/bios-community
ðĐš Twitter: bios_community
ðĶ LinkedIn: www.linkedin.com/company/bios-community
ð§ Substack: bioscommunity.substack.com
_______________________
BIOS: Nucleus of Life Science Innovation ð
Alix Ventures: Driving Patient Impact - Supporting Early Stage Startups Engineering Biology to Create Radical Advances in Human Healthð
Josh Mandel-Brehm is President & Chief Executive Officer of CAMP4 Therapeutics.
Mr. Mandel-Brehm was previously an entrepreneur partner with Polaris Partners and held key business development and operations leadership roles at leading biotech companies. Most recently he served as part of the Business Development group at Biogen, where he led multiple strategic activities and corresponding transactions. Prior to Biogen, Mr. Mandel-Brehm held several roles of increasing responsibility at Genzyme as part of the business development group for the companyâs rare disease business unit.
Mr. Mandel-Brehm earned a BA in Biology from Washington University in St. Louis and holds an MBA from the University of Michigan.
Host: Chris Ghadban
_______________________
Join BIOS Community ð
Become a member, continue the conversation, connect with like-minded Life Science innovators, access exclusive resources, & invite-only eventsâĶ
Apply to Join -docs.google.com/forms/d/e/1FAIpQLSft6P6HhSwMDJbFEW9j7HU6vZwjza9PRNN5ZdSGENj7HwhL7A/viewform
For More Interesting Content ð
ðĶū Website: www.bios.community/
𧎠Podcast: open.spotify.com/show/2HmcPq9k8fYpn60F3hw6Ra?si=uH9wk7SiRAiVUeP1dmwi7Q
𧊠Medium: medium.com/bios-community
ðĐš Twitter: bios_community
ðĶ LinkedIn: www.linkedin.com/company/bios-community
ð§ Substack: bioscommunity.substack.com
_______________________
BIOS: Nucleus of Life Science Innovation ð
Alix Ventures: Driving Patient Impact - Supporting Early Stage Startups Engineering Biology to Create Radical Advances in Human Healthð
āļĄāļļāļĄāļĄāļāļ: 154
āļ§āļĩāļāļĩāđāļ
Builders #32 w/ Lachlan MacKinnon & Adrian Woolfson - Founders @ Replay Bio | BIOS
āļĄāļļāļĄāļĄāļāļ 196āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Guests: Lachlan MacKinnon & Adrian Woolfson @ Replay Bio Lachlan MacKinnon - Co-Founder and Chief Executive Officer Lachlan is the Co-founder and CEO of Replay. He was previously a founding Principal at Oxford Science Enterprises (formerly OSI) where he made seed investments in companies at the intersection of technology and biology including investing the first capital in ONI, OMass Therapeuti...
Builders #31 w/ Charles Fisher - Founder & CEO @ Unlearn.AI | BIOS
āļĄāļļāļĄāļĄāļāļ 1362 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Guest: Charles Fisher - Founder & CEO @ Unlearn.AI Charles is a scientist with interests at the intersection of physics, machine learning, and computational biology. Previously, Charles worked as a machine learning engineer at Leap Motion and a computational biologist at Pfizer. He was a Philippe Meyer Fellow in theoretical physics at Ãcole Normale SupÃĐrieure in Paris, France, and a postdoctora...
Builders #30 w/ Sekar Kathiresan M.D. - Co-Founder & CEO @ Verve Therapeutics | BIOS
āļĄāļļāļĄāļĄāļāļ 4422 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Guest: Sekar Kathiresan M.D. - Co-Founder & CEO @ Verve Therapeutics Sekar Kathiresan is co-founder and chief executive officer of Verve Therapeutics. He is also a member of the companyâs board of directors. Dr. Kathiresan is a preventive cardiologist who has made groundbreaking discoveries of cardioprotective genetic mutations, which confer resistance to cardiovascular disease. Prior to joinin...
Ventures #25 w/ Ameena El-Bibany - Partner @ ARTIS Ventures | BIOS
āļĄāļļāļĄāļĄāļāļ 2502 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Guest: Ameena El-Bibany, Partner @ ARTIS Ventures Ameena is a Partner at ARTIS Ventures and currently sits on the Boards of Range Biotechnologies and Activ Surgical and is an investor in Inceptive Nucleics, among other companies. She has received recognition by Fortune as one of 11 VCs behind the hottest health tech deals and by the San Francisco Business Times as a 40 Under 40 honoree. Prior t...
Builders #29 w/ Seemay Chou - Co-Founder & CEO @ Arcadia Science | BIOS
āļĄāļļāļĄāļĄāļāļ 4993 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Guest: Seemay Chou - President & CEO @ Arcadia Science Dr. Seemay Chou, Ph.D. is the Co-Founder, CEO, and Board Member of Arcadia Science, a research and development company focusing on under researched areas in biology, with a specific focus on novel model organisms that haven't been traditionally studied in the lab. The goals of Arcadia Science are to unlock the knowledge and ingenuity contai...
Frontier Science #21 - Clinical Applications of Immunotherapies w/ Lili Yang - Prof. @ UCLA | BIOS
āļĄāļļāļĄāļĄāļāļ 2103 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Guest: Dr. Lili Yang is currently an Associate Professor at @UCLA. She received her Ph.D. degree in Biology from the California Institute of Technology (Caltech) in 2004, studying with the Nobel Laureate David Baltimore. Post graduation, she stayed at Caltech and led a multi-institutional Engineering Immunity Program from 2004 to 2012, developing gene- and cell-based immunotherapies for cancer ...
Builders #28 w/ Diego Rey - Co-Founder & CSO @ Endpoint Health | BIOS
āļĄāļļāļĄāļĄāļāļ 1533 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Guest: Diego Rey - Co-Founder & CSO @ Endpoint Health Diego is a skilled start-up executive, engineer, and scientist with extensive experience leading research efforts to develop products that help patients and physicians overcome healthcare obstacles. Prior to co-founding Endpoint Health, Diego invented the core technology and led investigational efforts related to Rocheâs antibiotic therapy g...
Ventures #24 w/ Jeffrey Low - Principal @ Novo Holdings, Growth Investments | BIOS
āļĄāļļāļĄāļĄāļāļ 2093 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Guest: Jeffrey Low, Principal @ Novo Holdings Jeffrey Low joined Growth Investments in 2020 as a Principal. Jeffrey focuses on investments in the life sciences and technology and is based in our San Francisco office. He joins us from Andreessen Horowitz where he established the firmâs therapeutics practice and actively invested at the intersection of life sciences, healthcare, and technology. J...
Builders #27 w/ Keith Gottesdiener - President & CEO @ Prime Medicine | BIOS
āļĄāļļāļĄāļĄāļāļ 4443 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Guest: Keith Gottesdiener - President & CEO @ Prime Medicine Keith Gottesdiener, MD is President and Chief Executive Officer of Prime Medicine and has served as a member of our Board of Directors since July 2020. From October 2011 until March 2020, Dr. Gottesdiener served as the Chief Executive Officer and a director of Rhythm Pharmaceuticals, Inc., a biopharmaceutical company that develops the...
Builders #26 w/ Sri Kosuri - Co-Founder & CEO @ Octant Bio | BIOS
āļĄāļļāļĄāļĄāļāļ 1863 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Guest: Sri Kosuri @ Octant Bio Sri Kosuri is the Co-Founder and CEO of Octant Bio, a data-driven therapeutics company pioneering a next-generation small molecule development platform leveraging synthetic biology, genome engineering, NGS, and computational tools. Sri is a scientist-entrepreneur with over two decades of experience in synthetic biology, functional genomics, and bioinformatics. He ...
Roundtable #9 - Future of Immunology w/ Vijay Kuchroo & Jeffrey Bluestone | BIOS
āļĄāļļāļĄāļĄāļāļ 7583 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Guests: Jeffrey Bluestone - Professor Emertius @ UCSF & Vijay Kuchroo - Professor @ Harvard Jeffrey Bluestone - A.W. and Mary Margaret Clausen Distinguished Professor Emeritus of Metabolism and Endocrinology at UCSF Jeff Bluestone is the President and Chief Executive Officer of Sonoma Biotherapeutics and the A.W. and Mary Margaret Clausen Distinguished Professor Emeritus at the Diabetes Center ...
Builders #25 w/ Marion Dorsch & Jared Rutter - Co-Founder & CSO / Co-Founder @ Atavistik Bio | BIOS
āļĄāļļāļĄāļĄāļāļ 2013 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Guests: Marion Dorsch & Jared Rutter, Co-Founders @ Atavistik Bio Marion Dorsch: President & CSO @ Atavistik Bio Marion Dorsch brings over 20 years of drug discovery experience in oncology, inflammation and rare genetic diseases to Atavistik Bio. She is an accomplished scientist and senior executive with a proven track record of discovering and advancing innovative therapies to patients. Most r...
Frontier Science #20 - Cancer Vaccines & Translational Medicine w/ Nora Disis - Prof. @ UW | BIOS
āļĄāļļāļĄāļĄāļāļ 3433 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Mary âNoraâ Disis, M.D., is director of the UW Institute of Translational Health Science and the UW Medicine Cancer Vaccine Institute. She is associate dean of Translational Science in the UW School of Medicine, Helen B. Slonaker Endowed Professor for Cancer Research, professor of Medicine and Oncology and adjunct professor of Obstetrics & Gynecology and Pathology. Dr. Disis believes patients a...
Builders #24 w/ Brian Fiske - Co-Founder & CSO @ Mythic Therapeutics | BIOS
āļĄāļļāļĄāļĄāļāļ 2474 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Guest: Brian Fiske - Co-Founder & CSO @ Mythic Therapeutics Brian is Chief Scientific Officer, Co-Founder, and Director of Mythic Therapeutics, a company pioneering the next-generation of antibody-drug conjugate (ADC) technology. Brian conceptualized and led the progression of the Companyâs R&D strategy, including its novel FateControlâĒ technology platform and its broader pipeline of next-gener...
Frontier Science #19 - Chemoproteomics w/ Dan Nomura - Professor @ UC Berkeley | BIOS
āļĄāļļāļĄāļĄāļāļ 5044 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Frontier Science #19 - Chemoproteomics w/ Dan Nomura - Professor @ UC Berkeley | BIOS
Future of DNA Supply w/ Tim Lu, Jake Becraft, Matt Hill, Patrick Boyle & Cristina Butterfield | BIOS
āļĄāļļāļĄāļĄāļāļ 3404 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Future of DNA Supply w/ Tim Lu, Jake Becraft, Matt Hill, Patrick Boyle & Cristina Butterfield | BIOS
Builders #23 w/ Tom Miller - Co-Founder & CEO @ Iambic Therapeutics | BIOS
āļĄāļļāļĄāļĄāļāļ 5068 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Builders #23 w/ Tom Miller - Co-Founder & CEO @ Iambic Therapeutics | BIOS
Builders #22 w/ Nabiha Saklayen - Co-Founder & CEO @ Cellino | BIOS
āļĄāļļāļĄāļĄāļāļ 3398 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Builders #22 w/ Nabiha Saklayen - Co-Founder & CEO @ Cellino | BIOS
Ventures #23 w/ Aaron Royston - Managing Partner @ venBio | BIOS
āļĄāļļāļĄāļĄāļāļ 2078 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Ventures #23 w/ Aaron Royston - Managing Partner @ venBio | BIOS
Roundtable #8 - World of OMICs w/ David Walt & Mike Snyder | BIOS
āļĄāļļāļĄāļĄāļāļ 6228 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Roundtable #8 - World of OMICs w/ David Walt & Mike Snyder | BIOS
Builders #21 w/ Paul Peter Tak - President & CEO @ Candel Therapeutics | BIOS
āļĄāļļāļĄāļĄāļāļ 5058 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Builders #21 w/ Paul Peter Tak - President & CEO @ Candel Therapeutics | BIOS
Builders #20 w/ Jake Becraft - Co-Founder & CEO @ Strand Therapeutics | BIOS
āļĄāļļāļĄāļĄāļāļ 3339 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Builders #20 w/ Jake Becraft - Co-Founder & CEO @ Strand Therapeutics | BIOS
Builders #19 w/ Ivan Dimov - Co-Founder & CEO @ Orca Bio | BIOS
āļĄāļļāļĄāļĄāļāļ 4479 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Builders #19 w/ Ivan Dimov - Co-Founder & CEO @ Orca Bio | BIOS
Roundtable #7 - Genetic & Cellular Engineering w/ David Schaffer & Samir Mitragotri | BIOS
āļĄāļļāļĄāļĄāļāļ 1.1K10 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Roundtable #7 - Genetic & Cellular Engineering w/ David Schaffer & Samir Mitragotri | BIOS
Builders #18 w/ Peter Smith - President & CEO @ Remix Therapeutics | BIOS
āļĄāļļāļĄāļĄāļāļ 28810 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Builders #18 w/ Peter Smith - President & CEO @ Remix Therapeutics | BIOS
Frontier Science #18 - Microbiome Therapeutics w/ Sarkis Mazmanian @ Caltech | BIOS
āļĄāļļāļĄāļĄāļāļ 56510 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Frontier Science #18 - Microbiome Therapeutics w/ Sarkis Mazmanian @ Caltech | BIOS
Builders #17 w/ Lee Cronin - Founder & CEO @ Chemify | BIOS
āļĄāļļāļĄāļĄāļāļ 1.6K10 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Builders #17 w/ Lee Cronin - Founder & CEO @ Chemify | BIOS
Ventures #22 w/ Andrew Hedin & Morgan Cheatham @ Bessemer Venture Partners | BIOS
āļĄāļļāļĄāļĄāļāļ 56411 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Ventures #22 w/ Andrew Hedin & Morgan Cheatham @ Bessemer Venture Partners | BIOS
Builders #16 w/ Chris Hart & Swagatam Mukhopadhyay - Co-Founders @ Creyon Bio | BIOS
āļĄāļļāļĄāļĄāļāļ 51211 āļŦāļĨāļēāļĒāđāļāļ·āļāļāļāđāļāļ
Builders #16 w/ Chris Hart & Swagatam Mukhopadhyay - Co-Founders @ Creyon Bio | BIOS
âĪthank
Why do I feel like the only person in the world right now that sees a stock beat down by 90% from its all time high, that has extreme obvious promise, and 90%+ institutional big money ownership as an asset you should be buying hand over fist?
Amazing! Love the philosophy.
I landed on your video and quality is really good, pls don't mind but I saw on your channel, you posted quite good number of videos and I can see the current reach is not that good. You can improve your reach by focusing collectively on thumbnails, specially in your niche improving SEO would be a deal breaker and ofc the video editing. and that's where I'm expert at.. If you want to talk on those lines then I would love to.
Please email chas@alix.vc
@bioscommunity BTW i sent you a mail! regarding it over the mail, but you didn't replied to itð
Great interview. Thanks.
very inspiring thank you
Glad you enjoyed it!
What an absolutely brilliant and creative guy - in so many ways. I hope he is wildly successful. Seems to be the analog to Wolfram Alpha in chemistry.
So grateful for the work Don Ingber is doing on behalf of the animals. And if I had cancer and needed treatment, I would be even more grateful
What is the name of the drug used in the 26 people study?
Pls donât be fooled by his self-deprecating humility. This is one of the sharpest minds in Science today -hands down.
Inspiring conversations
A m a z i n g!
Awesome
I would do most anything to share my project with maryanna !! Even if my idea was of no interest, I might gain something huge..
Love that!
ð
DOPEXCELLENCE!!!!!!!! GREAT ALL-STAR PANEL OF SOME OF THE WORLD'S BRILLIANT MINDS......
Great video! Keep going ðŠðŧ
very cool
Inspired is not enough to express how I feel from listening to Jonathan. Particularly: - "checking one's ego at the door and seeking help from partners because what matters most is getting to the patient as fast as possible." - "there are areas where we are strongest and areas where we are the weakest and we really do the patient a disservice if we try to do it all." - "I certainly got into this, to make a difference in people's lives" - "We're building a piece of a larger hole, we're in a continuity of human development." - "I'm always accessible. Anyone who's seeing this should always feel very welcome to reach out to me." - "Lean in and do it. Yes, it's challenging, yes, uphill the whole way. But the value of doing it is that you get to create a future that otherwise may never have existed." Well done Andrew, Chris and everyone at BIOS.
Great interview with George and Bob. ð
Love this interview!
ðð
great comments Arvind, very thoughtful